Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 1 or 2 Diabetes Mellitus treated with diet or medication~* Clinically or microbiologically documented foot infection below the knee~* Osteomyelitic bone must be removed within 48 hours of study entry~Exclusion Criteria:~* Uncomplicated skin infections~* Infected burn wounds~* Necrotizing fascitis~* Wounds with gangrene that cannot be removed with debridement~* Infections of prosthetic materials~* Foreign materials that can not be removed by surgical debridement~* Patients with another antibiotic 3 days prior to enrollment without evidence of treatment failure and presence of a positive culture~* Insufficient blood flow to the limb requiring a revascularization procedure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).